Jazz Pharmaceuticals plc  (Ireland) Share Price

Jazz Pharmaceuticals plc (Ireland) Share Price

NASDAQ: JAZZ | Large Cap
$207.82
+$2.99 (1.46%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Jazz Pharmaceuticals plc (Ireland) Stock Performance

Open
$207.09
Prev. Close
$204.83
Circuit Range
N/A
Day Range
$205.75 - $211.05
Year Range
$128.90 - $266.28
Volume
51,327
Average Traded
$208.72

Jazz Pharmaceuticals plc (Ireland) Share Price Today

As of 30 October 2026, Jazz Pharmaceuticals plc (Ireland)'s share price is $207.82. The stock opened at $207.09, compared to its previous close of $204.83. During today's trading session, Jazz Pharmaceuticals plc (Ireland)'s share price traded between $205.75 and $211.05, with an average price of $208.40. Over the past 52 weeks, the stock has recorded a high of $266.28 and a low of $128.90. In terms of performance, Jazz Pharmaceuticals plc (Ireland)'s share price has risen by 2.37% over the last six months and is up 51.01% on a year-on-year basis.

Jazz Pharmaceuticals plc (Ireland) Share Price Chart

Line chart of the Jazz Pharmaceuticals plc (Ireland) price trend over the selected period. The price rose overall, ranging from 205.70 to 210.99, ending at 207.75.
$205.75$211.05
L
Show Current Price
H

Jazz Pharmaceuticals plc (Ireland) Stock Fundamentals & Key Indicators

Market Cap
$12.67B
PE Ratio (TTM)
14.15
Dividend Yield
0.00%
EPS (TTM)
$14.49
Revenue (TTM)
$4.27T
Return On Equity (TTM)
19.59%
Profit Margin
-8.35%
Debt to Equity
0.91
Quarterly Earnings Growth YoY
-23.31%

Jazz Pharmaceuticals plc (Ireland) Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1126.11$1197.93$1068.90$1208.30
Net Profit$251.41$203.45$293.10$192.80
Net Profit Margin22.33%16.98%27.42%15.96%
Income ChangeN/A-19.08%44.06%-34.22%

Jazz Pharmaceuticals plc (Ireland) Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3659.37$3834.20$4068.95$4267.59
Net Profit-$224.06$414.83$560.12-$356.15
Net Profit Margin-6.12%10.82%13.77%-8.35%
Income ChangeN/A285.14%35.02%-163.58%

About Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals plc (Ireland) Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$230.99
$208.01
-10.23%
Sep 2026
$252.50
$231.72
-7.66%
Aug 2026
$253.13
$250.94
-0.63%
Jul 2026
$239.57
$252.54
+4.80%
Jun 2026
$235.50
$240.98
+1.82%
May 2026
$203.54
$236.68
+16.59%
Apr 2026
$190.13
$203.01
+7.53%
Mar 2026
$187.93
$188.79
-0.61%
Feb 2026
$165.48
$189.94
+15.45%
Jan 2026
$170.01
$164.52
-3.23%
Dec 2025
$174.76
$170.01
-3.78%
Nov 2025
$137.24
$176.68
+28.38%

JAZZ Share Price FAQs